These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18283232)

  • 1. Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System.
    Lattanzio F; Cherubini A; Furneri G; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2008 Feb; 20(1):76-80. PubMed ID: 18283232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.
    Romeo R; Knapp M; Hellier J; Dewey M; Ballard C; Baldwin R; Bentham P; Burns A; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Banerjee S
    Br J Psychiatry; 2013 Feb; 202():121-8. PubMed ID: 23258767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
    O'Connor CM; Glassman AH; Harrison DJ
    J Clin Psychiatry; 2005 Mar; 66(3):346-52. PubMed ID: 15766301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation.
    Roggeri DP; Roggeri A; Rossi E; Cinconze E; De Rosa M; Maggioni AP;
    Eur J Prev Cardiol; 2014 Sep; 21(9):1090-6. PubMed ID: 23515447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
    Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
    Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
    Jiang W; O'Connor C; Silva SG; Kuchibhatla M; Cuffe MS; Callwood DD; Zakhary B; Henke E; Arias RM; Krishnan R;
    Am Heart J; 2008 Sep; 156(3):437-44. PubMed ID: 18760123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.
    Swenson JR; O'Connor CM; Barton D; Van Zyl LT; Swedberg K; Forman LM; Gaffney M; Glassman AH;
    Am J Cardiol; 2003 Dec; 92(11):1271-6. PubMed ID: 14636902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, design, and baseline data for a multicenter randomized clinical trial comparing depression screening strategies after acute coronary syndrome: The comparison of depression identification after acute Coronary Syndromes-Quality of Life and Cost Outcomes (CODIACS-QOL) trial.
    Moise N; Davidson KW; Cheung YKK; Clarke GN; Dolor RJ; Duer-Hefele J; Ladapo JA; Margolis KL; St Onge T; Parsons F; Retuerto J; Schmit KM; Thanataveerat A; Kronish IM
    Contemp Clin Trials; 2019 Sep; 84():105826. PubMed ID: 31419605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
    Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
    J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
    Leelahanaj T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of depression: effect of adherence and treatment response.
    von Knorring L; Akerblad AC; Bengtsson F; Carlsson A; Ekselius L
    Eur Psychiatry; 2006 Sep; 21(6):349-54. PubMed ID: 16777385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of sertraline in the treatment of depression.
    Olvey EL; Skrepnek GH
    Expert Opin Pharmacother; 2008 Oct; 9(14):2497-508. PubMed ID: 18778187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study].
    Lange AP; Szucs TD
    Med Klin (Munich); 2004 Sep; 99(9):500-5. PubMed ID: 15372179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic consequences of ACS-related rehospitalizations in the US.
    Berenson K; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
    Curr Med Res Opin; 2010 Feb; 26(2):329-36. PubMed ID: 19968457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
    Solomon D; Adams J; Graves N
    J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study.
    Bainey KR; Gafni A; Rao-Melacini P; Tong W; Steg PG; Faxon DP; Lamy A; Granger CB; Yusuf S; Mehta SR;
    J Med Econ; 2014 Jun; 17(6):415-22. PubMed ID: 24702256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
    Shapiro PA; Lespérance F; Frasure-Smith N; O'Connor CM; Baker B; Jiang JW; Dorian P; Harrison W; Glassman AH
    Am Heart J; 1999 Jun; 137(6):1100-6. PubMed ID: 10347338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.
    Hegerl U; Hautzinger M; Mergl R; Kohnen R; Schütze M; Scheunemann W; Allgaier AK; Coyne J; Henkel V
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):31-44. PubMed ID: 19341510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.